Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07363577
PHASE3

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

Sponsor: LB Pharmaceuticals Inc.

View on ClinicalTrials.gov

Summary

This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult patients with an acute exacerbation of schizophrenia.

Official title: A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

456

Start Date

2026-03-25

Completion Date

2027-10

Last Updated

2026-05-06

Healthy Volunteers

No

Conditions

Interventions

DRUG

LB-102 (50 mg tablet)

LB-102 oral tablet given for six weeks

DRUG

LB-102 (100 mg tablet)

LB-102 oral tablet given for six weeks

OTHER

Placebo

Placebo tablet given orally for six weeks

Locations (13)

Pillar Clinical Research

Bentonville, Arkansas, United States

Pillar Clinical Research

Little Rock, Arkansas, United States

Woodland International Research Group

Little Rock, Arkansas, United States

ProScience Research Group

Culver City, California, United States

CenExel

Garden Grove, California, United States

Synergy San Diego

Lemon Grove, California, United States

Clinical Innovations, Inc.

Riverside, California, United States

Health Synergy Clinical Research

Boynton Beach, Florida, United States

Innovative Clinical Research

Miami Lakes, Florida, United States

Accelerated Clinical Trial

Snellville, Georgia, United States

Pillar Clinical Research

Chicago, Illinois, United States

Arch Clinical Trials

St Louis, Missouri, United States

Neuro-Behavioral Clinical Research

North Canton, Ohio, United States